<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>12</Volume><Issue>6</Issue><PubDate PubStatus="epublish"><Year>2021</Year><Month>10</Month><Day>13</Day></PubDate></Journal><title locale="en_US">Renin Angiotensin Converting Enzyme 2 and COVID‑19: Prevention and  Treatment</title><FirstPage>2482</FirstPage><LastPage>2482</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Physiology, Sazevar University of Medical Sciences, Sabzevar</affiliation></Author><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan  University of Medical Sciences, Isfahan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>13</Day></PubDate></History><abstract locale="en_US">Dear Editor, The 2019 novel corona virus (SARS‑CoV‑2) has already taken on pandemic proportions, having infected more than seven million people in 213 countries. The increased prevalence of the disease as well as involvement of the angiotensin‑converting enzyme 2 (ACE2) have suggested to consider its role in corona virus infection diseases‑2019 (COVID‑19).</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2482</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2482/717718322</pdf_url></Article></Articles>
